{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:59:31Z","timestamp":1740135571053,"version":"3.37.3"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T00:00:00Z","timestamp":1600646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670710","81770776"],"award-info":[{"award-number":["81670710","81770776"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Project Supported by Shanxi Scholarship Council of China","award":["2017-053","2020-172"],"award-info":[{"award-number":["2017-053","2020-172"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Congenital adrenal hyperplasia (CAH) with 17\u03b1-hydroxylase deficiency is a rare disease; patients often require lifetime cortisol treatment. In this case report, we presented a patient with CAH and 17\u03b1-hydroxylase deficiency, who was previously misdiagnosed as having primary aldosteronism. Furthermore, the flash glucose monitoring system (FGMS) was used to ascertain a suitable cortisol therapeutic regimen for this patient.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A 29-year-old woman presented with sex dysgenesis, hypertension and hypokalaemia. She had been diagnosed with primary aldosteronism at a local hospital. The re-measured aldosterone level in our hospital was below the normal range after antihypertensive medication adjustment, suggesting that the primary aldosteronism was a misdiagnosis. The patient was finally diagnosed as having CAH with 17\u03b1-hydroxylase deficiency according to the endocrine profile, adrenocorticotropic hormone stimulation test, and genetic analysis. Then, the patient was recommended cortisol treatment, during which the endocrine profile, blood pressure, plasma potassium level, and blood glucose level were observed to ascertain a suitable dosage. The FGMS was used to monitor blood glucose level, which indicated that the patient\u2019s glucose metabolism was maintained normally under the final treatment dosage.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>The misdiagnosis might have been because of the effects of the antihypertension medications on aldosterone and renin levels. The final dosage of cortisol treatment achieved a normal endocrine profile, while maintaining the homeostasis of blood glucose level, plasma potassium level and blood pressure. FGMS may be an effective method to ascertain a suitable cortisol therapeutic regimen for patients with CAH and 17\u03b1-hydroxylase deficiency.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12902-020-00625-1","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T13:03:52Z","timestamp":1600693432000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Flash glucose monitoring system was applied to cortisol treatment for a patient with congenital adrenal hyperplasia and 17\u03b1-hydroxylase deficiency"],"prefix":"10.1186","volume":"20","author":[{"given":"Chenyu","family":"Xiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minmin","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li\u2019e","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9864-444X","authenticated-orcid":false,"given":"Yunfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,21]]},"reference":[{"key":"625_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1196\/annals.1315.009","volume":"1038","author":"MI New","year":"2004","unstructured":"New MI. An update of congenital adrenal hyperplasia. Ann N Y Acad Sci. 2004;1038:14\u201343.","journal-title":"Ann N Y Acad Sci"},{"key":"625_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jsbmb.2016.02.002","volume":"165","author":"RJ Auchus","year":"2017","unstructured":"Auchus RJ. Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic. J Steroid Biochem Mol Biol. 2017;165:71\u20138.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"625_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0889-8529(08)70021-5","volume":"30","author":"RJ Auchus","year":"2001","unstructured":"Auchus RJ. The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinol Metab Clin N Am. 2001;30:101\u201319.","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"8","key":"625_CR4","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1515\/jpem-2020-0050","volume":"33","author":"AR Asirvatham","year":"2020","unstructured":"Asirvatham AR, Balachandran K, Jerome P, et al. Clinical, biochemical and genetic characteristics of children with congenital adrenal hyperplasia due to 17\u03b1-hydroxylase deficiency. J Pediatr Endocrinol Metab. 2020;33(8):1051\u20136.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"3","key":"625_CR5","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1055\/s-0031-1295460","volume":"44","author":"M Stowasser","year":"2012","unstructured":"Stowasser M, Ahmed AH, Pimenta E, et al. Factors affecting the aldosterone\/renin ratio. Horm Metab Res. 2012;44(3):170\u20136.","journal-title":"Horm Metab Res"},{"issue":"4","key":"625_CR6","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1046\/j.1365-2265.2002.01613.x","volume":"57","author":"C Seifarth","year":"2002","unstructured":"Seifarth C, Trenkel S, Schobel H, et al. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism. Clin Endocrinol. 2002;57(4):457\u201365.","journal-title":"Clin Endocrinol"},{"issue":"8","key":"625_CR7","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1055\/s-2007-978918","volume":"30","author":"A Tanabe","year":"1998","unstructured":"Tanabe A, Naruse M, Arai K, et al. Gene expression and roles of angiotensin II type 1 and type 2 receptors in human adrenals. Horm Metab Res. 1998;30(8):490\u20135.","journal-title":"Horm Metab Res"},{"issue":"4","key":"625_CR8","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1210\/en.2010-1070","volume":"152","author":"J Yatabe","year":"2011","unstructured":"Yatabe J, Yoneda M, Yatabe MS, et al. Angiotensin III stimulates aldosterone secretion from adrenal gland partially via angiotensin II type 2 receptor but not angiotensin II type 1 receptor. Endocrinol. 2011;152(4):1582\u20138.","journal-title":"Endocrinol."},{"issue":"7","key":"625_CR9","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2169\/internalmedicine.49.2749","volume":"49","author":"T Kondo","year":"2010","unstructured":"Kondo T, Goto R, Sonoda K, et al. Plasma renin activity and aldosterone concentration are not altered by the novel Calcium Channel antagonist, Azelnidipine, in hypertensive patients. Intern Med. 2010;49(7):637\u201343.","journal-title":"Intern Med"},{"issue":"3","key":"625_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/cen.12882","volume":"84","author":"GA Browne","year":"2016","unstructured":"Browne GA, Griffin TP, O'Shea PM, et al. \u03b2-Blocker withdrawal is preferable for accurate interpretation of the aldosterone-renin ratio in chronically treated hypertension. Clin Endocrinol. 2016;84(3):325\u201331.","journal-title":"Clin Endocrinol"},{"key":"625_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1507\/endocrj.EJ16-0387","volume":"65","author":"T Watanabe","year":"2018","unstructured":"Watanabe T, Ozawa A, Ishii S, et al. Usage of continuous glucose monitoring (CGM) for detecting an unrecognized hypoglycemia and management of glucocorticoid replacement therapy in adult patients with central hypoadrenalism. Endocr J. 2018;65:547\u201356.","journal-title":"Endocr J"},{"issue":"2","key":"625_CR12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41371-017-0002-5","volume":"32","author":"L Hinz","year":"2018","unstructured":"Hinz L, Pacaud D, Kline G. Congenital adrenal hyperplasia causing hypertension: an illustrative review. J Hum Hypertens. 2018;32(2):150\u20137.","journal-title":"J Hum Hypertens"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-020-00625-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-020-00625-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-020-00625-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T23:26:24Z","timestamp":1632180384000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-020-00625-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,21]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["625"],"URL":"https:\/\/doi.org\/10.1186\/s12902-020-00625-1","relation":{},"ISSN":["1472-6823"],"issn-type":[{"type":"electronic","value":"1472-6823"}],"subject":[],"published":{"date-parts":[[2020,9,21]]},"assertion":[{"value":"15 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been approved by the Ethics Committee of First Hospital of the Shanxi Medical University (2018\u2009K002).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We have obtained the written informed consent from the patients and her parents to publish this article. They were informed that information related to them in this article would be freely available on the internet and may be seen by general public. Copies of consent forms are available to be reviewed by the editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no competing interests among authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"144"}}